Previous 10 | Next 10 |
IRVINE, CA, May 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS ), a U.S. company specializing in the research and development of cannabinoid-based medicines, is proud to announce it has been introduced as one of the key industry partners i...
IRVINE, CA, May 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company’s participation in the 2019 Global Health Catalyst (GHC) Summi...
IRVINE, CA, May 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the upcoming Global Health Catalyst (GHC) Summit at Harvard Medical School h...
IRVINE, CA, May 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, has entered into a new Research Collaboration Agreement with Dana-Farber Cancer Institute, Inc. to investigate ...
The marijuana sector of the stock market has been a wild one. I first became interested in this segment in 2013, when in the midst of a growing optimism in the future of the legalised marijuana industry, we saw a huge bull run in every listed marijuana-related stock (see 5 Marijuana Stocks Go...
IRVINE, CA, May 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, hits inflection point that translates into an unprecedented progression to clinical trials. With this ch...
Cannabis Science’ CBN Patent is for the Treatment of Neurological Conditions, Including Sleep Deprivation, Anxiety, PTSD, and More IRVINE, CA, April 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the devel...
IRVINE, CA, April 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that the Company’s strategic partner in South Africa, Elpasso Farms, has...
April 1, 2019 Palm Beach, FL – April 1, 2019 – A recent article in CannabizDaily, an industry newsletter, focused on the reasons hemp biomass, although not a ‘sexy’ label… can be the source of significant revenues in the ever-expanding industry. It sa...
New Jersey lawmakers have canceled their planned vote on Monday, April 1, on legalizing the recreational use of marijuana for adults at least 21 years old. More news on: Cronos Group Inc., Canopy Growth Corporation, Tilray, Inc., Healthcare stocks news, Consumer stocks news, News on ETFs...
News, Short Squeeze, Breakout and More Instantly...
Cannabis Science Inc Company Name:
CBIS Stock Symbol:
OTCMKTS Market:
All CSi-EDP Project Assignments Based on Project Valuations and $CSI Crypto Valuations Amsterdam, Netherlands, Aug. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Cannabis Science Inc., formerly known as (CBIS) per its previous trading history on the OTC Markets Exchange, is...
https://cannabissciencecoin.com/ All CSi-EDP Project Assignments Based on Project Valuations and $CSI Crypto Valuations Amsterdam, Netherlands, Aug. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Cannabis Science Inc., Formerly known as (CBIS) per its previous trading history ...
Have You Heard Of These Marijuana Stocks? The cannabis industry of recent has been tough, to say the least. One day marijuana stocks are up, and the next, the cannabis market is down. Although we as investors are used to this high level of volatility, the past two months have been much mor...